Literature DB >> 2327752

Diverse potential of beta-lactamase inhibitors to induce class I enzymes.

D A Weber1, C C Sanders.   

Abstract

The ability of various beta-lactamase inhibitors to induce class I beta-lactamases was assessed. Clavulanate was the most active compound, inducing Morganella morganii, Aeromonas caviae, and Enterobacter aerogenes over a broad concentration range and Citrobacter freundii, Pseudomonas aeruginosa, and Serratia marcescens at high concentrations. Disk approximation tests paralleled these results, with clavulanate, but not sulbactam or tazobactam, antagonizing the activity of several beta-lactams against these organisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2327752      PMCID: PMC171539          DOI: 10.1128/AAC.34.1.156

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam.

Authors:  F Moosdeen; J D Williams; S Yamabe
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

2.  Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases.

Authors:  L Gutmann; M D Kitzis; S Yamabe; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

3.  Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.

Authors:  C C Sanders; W E Sanders
Journal:  J Infect Dis       Date:  1986-11       Impact factor: 5.226

Review 4.  Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics.

Authors:  C C Sanders
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

5.  Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae.

Authors:  S Minami; A Yotsuji; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

6.  Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.

Authors:  F Moosdeen; J Keeble; J D Williams
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

7.  The effects of clavulanic acid and sulbactam on beta-lactamase biosynthesis.

Authors:  T H Farmer; C Reading
Journal:  J Antimicrob Chemother       Date:  1988-08       Impact factor: 5.790

8.  Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

9.  Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice.

Authors:  R V Goering; C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

10.  In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics.

Authors:  N A Kuck; R T Testa; M Forbes
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

View more
  21 in total

1.  Emergence of resistance to beta-lactam agents in Pseudomonas aeruginosa with group I beta-lactamases in Spain.

Authors:  K Colom; A Fdz-Aranguiz; E Suinaga; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

2.  Induction potential of clavulanic acid toward L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.

Authors:  C-W Lin; R-M Hu; S-C Huang; Y-J Hsiao; T-C Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-01       Impact factor: 3.267

Review 3.  Updated functional classification of beta-lactamases.

Authors:  Karen Bush; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

Review 4.  A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.

Authors:  Pranita D Tamma; Yohei Doi; Robert A Bonomo; J Kristie Johnson; Patricia J Simner
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

Review 5.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 6.  β-Lactams and β-Lactamase Inhibitors: An Overview.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

7.  Comparison of four antimicrobial susceptibility testing methods to determine the in vitro activities of piperacillin and piperacillin-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  James A Karlowsky; Mellany K Weaver; Clyde Thornsberry; Michael J Dowzicky; Mark E Jones; Daniel F Sahm
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes.

Authors:  S J Cavalieri; C C Sanders; C New
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

9.  Imipenem resistance in Enterobacter.

Authors:  K S Thomson; C C Sanders; H Chmel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

10.  Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.

Authors:  K Bush; R K Flamm; S Ohringer; S B Singer; R Summerill; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.